C0036825||Serum Protein
C0005516||Biomarker
C0027651||Tumor
C0004358||Autoantibody
C1171362||Expression
C1510438||Blood-Based Proteomic Assay
C0006142||Breast Cancer
C1134632||breast imaging
C0442726||detect
C0006142||Breast Cancer
C0006142||Breast Cancer
C0005516||key biomarkers
C3463810||protein signatures
C0006142||Breast Cancer
C1327760||proteomic
C3161326||diagnostic adjunct
C0011923||imaging
C0681814||Research studies
C0006142||breast tumors
C0005516||serum protein biomarkers
C0005516||serum protein biomarkers
C0004358||tumor associated autoantibodies
C0004358||tumor associated autoantibodies
C0005516||serum protein biomarkers
C0004358||tumor associated autoantibodies
C1171362||expression
C0006142||Breast Cancer
C0005516||serum protein biomarkers
C0004358||tumor associated autoantibodies
C2603343||study
C0220825||evaluates
C2985505||retrospective cohort
C0005558||biopsy
C1550100||serum samples
C0456984||clinical outcomes
C1515974||site
C1846356||variation
C0005516||serum protein biomarkers
C0004358||tumor associated autoantibodies
C0006142||Breast Cancer
C1550100||serum samples
C0005558||biopsy
C0679646||participants
C1276755||no evidence of breast disease
C1276755||ND
C0679646||participants
C0011900||diagnosed
C0016034||Benign Breast Disease
C0016034||Benign Breast Disease
C0679646||participants
C0011900||diagnosed
C0006142||Breast Cancer
C0007124||DCIS
C0016034||Benign Breast Disease
C0006142||Breast Cancer
C0011900||diagnoses
C0030664||pathology
C0005558||biopsy
C0026348||Statistical models
C0006142||Breast Cancer
C0016034||Benign Breast Disease
C1276755||ND
C1171362||expression
C0005516||serum protein biomarkers
C0004358||tumor associated autoantibodies
C0005516||serum protein biomarkers
C0004358||tumor associated autoantibodies
C0005516||serum protein biomarkers
C0870071||modeling
C1516631||clinical sensitivity
C0006142||Breast Cancer
C0004358||tumor associated autoantibodies
C1516631||clinical sensitivity
C0442726||detection
C0006142||Breast Cancer
C0870071||modeling
C0005516||serum protein biomarkers
C0004358||tumor associated autoantibodies
C1516631||clinical sensitivity
C0006142||Breast Cancer
C0005516||serum protein biomarkers
C0004358||tumor associated autoantibodies
C0006142||Breast Cancer